InvestorsHub Logo
Followers 7
Posts 112
Boards Moderated 0
Alias Born 08/01/2019

Re: Lykiri post# 281322

Monday, 05/04/2020 10:50:00 AM

Monday, May 04, 2020 10:50:00 AM

Post# of 731301
From ASCO 2019 : Although not specifically mentioned, seems like DCVax-L should be the leader in below generic category ( PIII complete ... ) :

" The most exciting vaccines are the ones that sequence a tumor to look
for neoantigens and develop personalized vaccines against neoantigens "

Dr. Patrick Wen

https://user-5j6avhy.cld.bz/PracticeUpdate-Oncology-Best-of-2019/14/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News